Log in

Arch Therapeutics News Headlines (OTCMKTS:ARTH)

$0.16
0.00 (0.00 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$0.16
Now: $0.16
$0.16
50-Day Range
$0.16
MA: $0.25
$0.28
52-Week Range
$0.15
Now: $0.16
$0.62
Volume2.24 million shs
Average Volume531,684 shs
Market Capitalization$28.12 million
P/E RatioN/A
Dividend YieldN/A
Beta0.11

Headlines

Arch Therapeutics (OTCMKTS ARTH) News Headlines

Source:
DateHeadline
Arch Therapeutics launches $2.5M registered direct offeringArch Therapeutics launches $2.5M registered direct offering
seekingalpha.com - October 17 at 12:22 PM
Arch Therapeutics Announces $2.5 Million Registered Direct OfferingArch Therapeutics Announces $2.5 Million Registered Direct Offering
finance.yahoo.com - October 17 at 12:22 PM
Arch Therapeutics Provides Corporate Update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NYArch Therapeutics Provides Corporate Update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NY
finance.yahoo.com - October 7 at 2:27 PM
Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 21st Annual Global Investment ConferenceArch Therapeutics to Provide Corporate Update at the H.C. Wainwright 21st Annual Global Investment Conference
finance.yahoo.com - September 3 at 8:36 AM
Arch Therapeutics in the green as AC5 nears CE Mark certificationArch Therapeutics in the green as AC5 nears CE Mark certification
seekingalpha.com - August 5 at 11:47 PM
Arch Therapeutics Announces AC5 Self-Assembling Peptide Technology Platform Demonstrates Antimicrobial Activity in Two Studies and Provides CE Marking Status Update for AC5™ Topical HemostatArch Therapeutics Announces AC5 Self-Assembling Peptide Technology Platform Demonstrates Antimicrobial Activity in Two Studies and Provides CE Marking Status Update for AC5™ Topical Hemostat
finance.yahoo.com - August 5 at 8:52 AM
Arch Therapeutics to Provide Corporate Update at the 9th Annual LD Micro InvitationalArch Therapeutics to Provide Corporate Update at the 9th Annual LD Micro Invitational
finance.yahoo.com - May 30 at 8:22 AM
Arch Therapeutics prices $2.8M registered direct offeringArch Therapeutics prices $2.8M registered direct offering
seekingalpha.com - May 13 at 7:59 PM
Arch Therapeutics, Inc. $2.8 Million Registered Direct OfferingArch Therapeutics, Inc. $2.8 Million Registered Direct Offering
finance.yahoo.com - May 13 at 8:12 AM
Arch Therapeutics Announces Attendance at 2019 Symposium on Advanced Wound Care Conference (SAWC) and Release of a New AC5TM Topical Gel VideoArch Therapeutics Announces Attendance at 2019 Symposium on Advanced Wound Care Conference (SAWC) and Release of a New AC5TM Topical Gel Video
finance.yahoo.com - April 24 at 8:16 AM
Arch Therapeutics to Provide Corporate Update at the 31st Annual ROTH ConferenceArch Therapeutics to Provide Corporate Update at the 31st Annual ROTH Conference
finance.yahoo.com - March 11 at 7:47 PM
Arch Therapeutics to Provide Corporate Update at the 2019 BIO CEO & Investor ConferenceArch Therapeutics to Provide Corporate Update at the 2019 BIO CEO & Investor Conference
finance.yahoo.com - February 5 at 6:35 PM
Arch Therapeutics to Provide Corporate Update at the 11th Annual Biotech Showcase™ 2019 Conference on January 8th, 2019Arch Therapeutics to Provide Corporate Update at the 11th Annual Biotech Showcase™ 2019 Conference on January 8th, 2019
finance.yahoo.com - December 20 at 8:14 AM
Form 8-K Arch Therapeutics, Inc. For: Dec 17 - StreetInsider.comForm 8-K Arch Therapeutics, Inc. For: Dec 17 - StreetInsider.com
www.streetinsider.com - December 18 at 8:13 AM
Arch Therapeutics Receives 510(k) Clearance from the US FDA for AC5™ Topical GelArch Therapeutics Receives 510(k) Clearance from the US FDA for AC5™ Topical Gel
finance.yahoo.com - December 17 at 8:12 AM
Arch Therapeutics, Inc. (ARTH) Reports Positive Outcome of Ruling from Japanese Intellectual Property High CourtArch Therapeutics, Inc. (ARTH) Reports Positive Outcome of Ruling from Japanese Intellectual Property High Court
www.streetinsider.com - December 8 at 5:16 PM
Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main EventArch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event
finance.yahoo.com - December 6 at 8:19 AM
Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court - NasdaqArch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court - Nasdaq
www.nasdaq.com - December 4 at 5:42 PM
Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court - GlobeNewswireArch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court - GlobeNewswire
globenewswire.com - December 4 at 8:19 AM
Form 8-K Arch Therapeutics, Inc. For: Dec 04 - StreetInsider.comForm 8-K Arch Therapeutics, Inc. For: Dec 04 - StreetInsider.com
www.streetinsider.com - December 4 at 8:19 AM
Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High CourtArch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court
finance.yahoo.com - December 4 at 8:19 AM
Form 8-K Arch Therapeutics, Inc. For: Nov 26 - StreetInsider.comForm 8-K Arch Therapeutics, Inc. For: Nov 26 - StreetInsider.com
www.streetinsider.com - November 28 at 8:20 AM
Arch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat in Europe - GlobeNewswireArch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat in Europe - GlobeNewswire
globenewswire.com - November 28 at 8:20 AM
Arch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat in EuropeArch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat in Europe
finance.yahoo.com - November 28 at 8:20 AM
Arch Therapeutics to Provide Corporate Update at the 11th Annual LD Micro Main Event on Tuesday, December 4, 2018Arch Therapeutics to Provide Corporate Update at the 11th Annual LD Micro Main Event on Tuesday, December 4, 2018
finance.yahoo.com - November 26 at 8:11 AM
Arch Therapeutics to Provide Corporate Update at the Ladenburg Thalmann 2018 Healthcare Conference on Tuesday ...Arch Therapeutics to Provide Corporate Update at the Ladenburg Thalmann 2018 Healthcare Conference on Tuesday ...
www.nasdaq.com - September 25 at 5:01 PM
Arch Therapeutics to Provide Corporate Update at the Ladenburg Thalmann 2018 Healthcare Conference on Tuesday, October 2, 2018Arch Therapeutics to Provide Corporate Update at the Ladenburg Thalmann 2018 Healthcare Conference on Tuesday, October 2, 2018
finance.yahoo.com - September 25 at 8:11 AM
Arch Therapeutics, Inc. (ARTH) Announces Topline Results from Skin Sensitization Study of AC5Arch Therapeutics, Inc. (ARTH) Announces Topline Results from Skin Sensitization Study of AC5
www.streetinsider.com - September 6 at 8:18 AM
Arch Therapeutics Reports Topline Results from Skin Sensitization Study of AC5Arch Therapeutics Reports Topline Results from Skin Sensitization Study of AC5
finance.yahoo.com - September 5 at 8:16 AM
Arch Therapeutics to Provide Corporate Update at...Arch Therapeutics to Provide Corporate Update at...
www.benzinga.com - August 28 at 8:12 AM
Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 20th Annual Global Investment Conference on Wednesday, September 5, 2018Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 20th Annual Global Investment Conference on Wednesday, September 5, 2018
finance.yahoo.com - August 28 at 8:12 AM
Arch Therapeutics Announces Poster Presentation at the 2018 Military Health System Research Symposium on Tuesday, August 21, 2018Arch Therapeutics Announces Poster Presentation at the 2018 Military Health System Research Symposium on Tuesday, August 21, 2018
finance.yahoo.com - August 16 at 8:14 AM
Arch Therapeutics Appoints Healthcare Industry Executive Punit Dhillon to Board of DirectorsArch Therapeutics Appoints Healthcare Industry Executive Punit Dhillon to Board of Directors
finance.yahoo.com - July 20 at 8:14 AM
Arch Therapeutics, Inc. $4.5 Million Registered Direct OfferingArch Therapeutics, Inc. $4.5 Million Registered Direct Offering
finance.yahoo.com - June 30 at 9:18 AM
Arch Therapeutics Provides Skin Sensitization Study Status UpdateArch Therapeutics Provides Skin Sensitization Study Status Update
finance.yahoo.com - June 26 at 8:28 AM
Arch Therapeutics Completes Enrollment and Initiates Dosing in Skin Sensitization StudyArch Therapeutics Completes Enrollment and Initiates Dosing in Skin Sensitization Study
finance.yahoo.com - June 15 at 8:12 AM
Arch Therapeutics to Provide Corporate Update at the 8th LD Micro Invitational on Monday, June 4, 2018Arch Therapeutics to Provide Corporate Update at the 8th LD Micro Invitational on Monday, June 4, 2018
finance.yahoo.com - May 15 at 8:19 AM
Arch Therapeutics Provides Update on Study Initiation and 510(k)Arch Therapeutics Provides Update on Study Initiation and 510(k)
finance.yahoo.com - May 8 at 8:10 AM
IFS Securities Downgrades Arch Therapeutics (ARTH) to OutperformIFS Securities Downgrades Arch Therapeutics (ARTH) to Outperform
www.streetinsider.com - March 14 at 7:13 PM
FDA Places Clinical Hold On ADXS Study, ALT Proves A Good Shot, RYTM On Track - NasdaqFDA Places Clinical Hold On ADXS Study, ALT Proves A Good Shot, RYTM On Track - Nasdaq
www.nasdaq.com - March 13 at 8:17 AM
Form 8-K Arch Therapeutics, Inc. For: Mar 12 - StreetInsider.comForm 8-K Arch Therapeutics, Inc. For: Mar 12 - StreetInsider.com
www.streetinsider.com - March 13 at 8:17 AM
Arch Therapeutics Provides Update on 510(k) - GlobeNewswire (press release)Arch Therapeutics Provides Update on 510(k) - GlobeNewswire (press release)
www.globenewswire.com - March 13 at 8:17 AM
Arch Therapeutics Provides Update on 510(k) - NasdaqArch Therapeutics Provides Update on 510(k) - Nasdaq
www.nasdaq.com - March 12 at 6:44 PM
Arch Therapeutics Provides Update on 510(k)Arch Therapeutics Provides Update on 510(k)
finance.yahoo.com - March 12 at 6:44 PM
Form 4 Juno Therapeutics, Inc. For: Mar 05 Filed by: NELSEN ROBERTForm 4 Juno Therapeutics, Inc. For: Mar 05 Filed by: NELSEN ROBERT
www.streetinsider.com - March 9 at 6:58 PM
Arch Therapeutics to Provide Corporate Update at the 30th Annual Roth Conference on March 12, 2018 - GlobeNewswire (press release)Arch Therapeutics to Provide Corporate Update at the 30th Annual Roth Conference on March 12, 2018 - GlobeNewswire (press release)
globenewswire.com - March 5 at 8:12 AM
Dermatologic Surgery Publishes Clinical Data on Arch Therapeutics ... - GlobeNewswire (press release)Dermatologic Surgery Publishes Clinical Data on Arch Therapeutics ... - GlobeNewswire (press release)
globenewswire.com - February 5 at 3:37 PM
Dermatologic Surgery Publishes Clinical Data on Arch Therapeutics’ AC5™ in a Topical ApplicationDermatologic Surgery Publishes Clinical Data on Arch Therapeutics’ AC5™ in a Topical Application
finance.yahoo.com - February 5 at 8:58 AM
Arch Therapeutics to Provide Corporate Update at The 10th Annual Biotech Showcase™ 2018 Conference on January ... - GlobeNewswire (press release)Arch Therapeutics to Provide Corporate Update at The 10th Annual Biotech Showcase™ 2018 Conference on January ... - GlobeNewswire (press release)
globenewswire.com - January 2 at 4:59 PM
Arch Therapeutics Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA - GlobeNewswire (press release)Arch Therapeutics Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA - GlobeNewswire (press release)
globenewswire.com - December 19 at 11:18 AM
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel